Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.2K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Actuarial Approach01:20

Actuarial Approach

374
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
374
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

742
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
742
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

711
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
711
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

579
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
579

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

3D-QSAR model of flavonoids binding at benzodiazepine site in GABAA receptors.

Journal of medicinal chemistry·2001
Same author

Cloning of differentially expressed genes in an HIV-1 resistant T cell clone by rapid subtraction hybridization, RaSH.

Gene·2001
Same author

17 beta-estradiol protects neurons from ischemic damage and attenuates accumulation of extracellular excitatory amino acids.

Anesthesia and analgesia·2001
Same author

Involvement of hepatocyte nuclear factor-4 in the expression of the growth hormone receptor 1A messenger ribonucleic acid in bovine liver.

Molecular endocrinology (Baltimore, Md.)·2001
Same author

En bloc transplation of kidney and whole pancreas with a segment of duodenum in rats.

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih·2001
Same author

[Diagnostic value of human cytomegalovirus late-mRNA detection for intrauterine active human cytomegalovirus infection].

Zhonghua fu chan ke za zhi·2001
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

Inference on cancer screening exam accuracy using population-level administrative data.

H Jiang1, P E Brown1,2,3, S D Walter2

  • 1Analytics Informatics, Cancer Care Ontario, Toronto, ON, Canada.

Statistics in Medicine
|August 18, 2015
PubMed
Summary
This summary is machine-generated.

This study presents a new statistical model for cancer screening data, improving accuracy in estimating disease prevalence and diagnostic performance. The model accounts for unobserved factors and dependencies between screening exams.

Keywords:
Bayesian inferencecancer screeningclustered analysislatent-class modelrandom effecttest accuracy

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Related Experiment Videos

Last Updated: Apr 5, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Medical Informatics

Background:

  • Cancer screening programs generate complex data with unobserved disease status and potential dependencies between repeated exams.
  • Accurate estimation of diagnostic accuracy and disease prevalence is crucial for effective cancer screening strategies.
  • Existing models may not fully capture the intricacies of screening data, including clustered structures and covariate effects.

Purpose of the Study:

  • To develop a flexible statistical model for analyzing cancer screening and incidence data.
  • To estimate diagnostic error rates and disease prevalence while accounting for latent disease status and exam dependencies.
  • To apply the developed Bayesian approach to real-world data for evaluating mammography and clinical breast examination accuracy.

Main Methods:

  • Development of a Bayesian statistical model incorporating latent variables for unobserved cancer and detection status.
  • Utilizing a Markov Chain Monte Carlo (MCMC) algorithm for estimating posterior distributions of model parameters.
  • Modeling conditional dependence between multiple screening exams within the statistical framework.

Main Results:

  • The proposed model effectively handles partially unobserved disease status and clustered data structures.
  • Bayesian inference provides robust estimates of diagnostic error rates and disease prevalence.
  • The application to the Ontario Breast Screening Program demonstrates the model's utility in assessing mammography and clinical breast examination accuracy.

Conclusions:

  • The developed Bayesian model offers a powerful tool for analyzing complex cancer screening data.
  • The methodology allows for accurate inference on screening test properties and disease prevalence, even with dependent exams.
  • This approach enhances the understanding of diagnostic accuracy in breast cancer screening programs.